MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health Long Term Debt Current 2011-2026 | OPK
Annual Long Term Debt Current OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6 M | 13 M | 11.6 M | 11.6 M | 9.03 M | 12 M | - | 11.9 M | 12 M | 11.5 M | 13.5 M | 12.6 M | - | 8.76 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.5 M | 8.76 M | 11.7 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Biodesix
BDSX
|
719 K | $ 15.17 | 3.27 % | $ 1.97 B |  USA |
 |
Biomerica
BMRA
|
358 K | $ 2.12 | -0.47 % | $ 4.87 M | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 74.9 | -1.1 % | $ 5.05 B | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 459.32 | 0.52 % | $ 13.2 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
838 K | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.78 | 2.47 % | $ 443 M | USA |
 |
National Research Corporation
NRC
|
451 K | $ 17.42 | -0.51 % | $ 390 M | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 159.35 | 0.79 % | $ 7.9 B | USA |
 |
IQVIA Holdings
IQV
|
93 M | $ 164.84 | -1.3 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
697 K | $ 1.18 | -19.01 % | $ 6.43 M | USA |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 259.61 | 1.55 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
383 K | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
79 M | $ 125.09 | 1.05 % | $ 19.9 B | USA |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 1.4 | 0.36 % | $ 420 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
218 K | $ 26.8 | -0.48 % | $ 34.8 M | USA |
 |
Personalis
PSNL
|
7.7 M | $ 7.82 | 2.76 % | $ 463 M | USA |
 |
Celcuity
CELC
|
172 K | $ 103.35 | -3.19 % | $ 4.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 265.46 | 0.37 % | $ 22.1 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
RadNet
RDNT
|
61.9 M | $ 59.99 | -2.84 % | $ 4.51 B | USA |
 |
ENDRA Life Sciences
NDRA
|
96.9 K | $ 3.36 | -3.45 % | $ 1.8 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.03 | -0.86 % | $ 1.03 B | USA |
 |
Natera
NTRA
|
7.64 M | $ 195.57 | -2.26 % | $ 19.2 B | USA |
 |
Senseonics Holdings
SENS
|
496 K | $ 6.73 | 1.59 % | $ 281 M | USA |
 |
Sotera Health Company
SHC
|
5.76 M | $ 13.88 | -0.04 % | $ 3.94 B | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 17.57 | 0.06 % | $ 936 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 25.42 | -1.28 % | $ 706 M | USA |
 |
Neuronetics
STIM
|
5.56 M | $ 1.48 | -7.81 % | $ 97.6 M | USA |
 |
DarioHealth Corp.
DRIO
|
430 K | $ 7.5 | 0.03 % | $ 29.9 M | Israel |
 |
DexCom
DXCM
|
21.6 M | $ 66.27 | 0.5 % | $ 25.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | $ 104.91 | - | $ 19.8 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |